Hedge Funds Pile Into Tiny Biotech That’s Already Soared 460%

(Bloomberg) -- Hedge funds swarmed into Trillium Therapeutics Inc. in the first quarter, with at least 10 firms taking new stakes in the health-care company.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.